Company news
Vivos Therapeutics, Inc. news in 2021
Vivos Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Vivos Therapeutics Announces Registration with Health Canada to Manufacture and Sell Sleep Disorder, Snoring and Sleep Apnea Appliances to Canadian Dentists
December 8, 2021
Vivos Therapeutics Reports Third Quarter 2021 Financial Results and Operational Update
November 14, 2021
Vivos Therapeutics Schedules Third Quarter 2021 Financial Results Conference Call
November 8, 2021
Vivos Therapeutics Announces 2021 Annual Breathing Wellness Conference Presented by The Vivos Institute
October 18, 2021
Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution
October 17, 2021
Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company’s Technology for Obstructive Sleep Apnea
September 22, 2021
Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment
August 25, 2021
FDA Grants 510(k) Market Clearance to Vivos Therapeutics’ mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea
August 22, 2021
Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update
August 11, 2021
Vivos Therapeutics Schedules Second Quarter 2021 Financial Results Conference Call
August 8, 2021
Vivos Therapeutics Opens State of the Art International Training Center In Denver
July 28, 2021
Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update
May 16, 2021
Vivos Therapeutics Schedules First Quarter 2021 Financial Results Conference Call
May 12, 2021
Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
May 10, 2021
Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering
May 5, 2021
Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi Guarneri as New Medical Director of Clinical Education
April 13, 2021
Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service
March 29, 2021
Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
March 24, 2021
Vivos Therapeutics Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 5: 00 pm ET
March 17, 2021
Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center
March 7, 2021
Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults
February 15, 2021
Vivos Therapeutics Submits FDA 510(k) Application for the Vivos mmRNA Oral Appliance
February 1, 2021
Vivos Therapeutics Forms Clinical Advisory Board to Drive Further Growth of Next-Generation Obstructive Sleep Apnea Treatment Efforts
January 28, 2021
Vivos Therapeutics Launches AireO2 Patient Management Technology to Treat Patients with Obstructive Sleep Apnea
January 5, 2021